Safety and Low Back Pain Relieving Effect of Tepthara Formulary

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

TCTR

Registry ID

TCTR20170818006

Enrollment

Unknown

Registered

2017-08-18

Start date

2008-01-31

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low back pain. low back pain plant preparations observational study

Interventions

patient received one 500 mg capsule of Tepthara formulary of 12 Thai herb for 3 times per day before meals for 14 days.

Supportive Care

tepthara formulary

Eligibility

Sex/Gender

All

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: patient who have symtomps low back pain and got diagnosis form doctor. about LBP select by ICD 10. take more than one visit of Teptara in Uthong hospital since 2006-2016.

Exclusion criteria

Exclusion criteria: age < 18 years history of allergy to any of the herbs uesd in this study who used to get diagnosis about serious history of fracture/dislocation/surgery of spine

Design outcomes

Primary

Measure	Time frame
clinical improvement 2 months the record of physician decision	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactDalicha Chungsiriporn

Uthong Hospital

dalicha168@gmail.com0819810568

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026